Substituted Pyridine Synthesis Without Intermediate Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic routes for substituted pyridine compounds are inefficient and resource-intensive, particularly when scaled up, due to the use of multiple steps, high or low temperatures, and chromatographic purification methods, which hinder large-scale production and introduce processing challenges.
Innovation Solution
A method involving sequential reactions with o-tolylmagnesium chloride, N-methylpiperazine, iodine, and 3,5-bis(trifluoromethyl)benzyl bromide, along with the formation of a dihydrochloride salt, allows for the synthesis of substituted pyridine compounds in high yields and large scales without isolation of intermediates, using mild temperatures and simple purification procedures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional synthetic routes with multiple steps and chromatographic purification are used, then compound purity is achieved, but productivity and manufacturing efficiency deteriorate
Solution Approach 1:
The invention extracts and eliminates the chromatographic purification step from the synthetic route. Instead of using column chromatography for purification, the method employs a streamlined sequence of reactions followed by simple filtration and concentration steps, thereby maintaining product purity while dramatically improving manufacturing efficiency and productivity.
Solution Approach 2:
The invention merges multiple synthetic steps into a more integrated process. The sequential treatment with o-tolylmagnesium chloride, N-methylpiperazine, and iodine is followed directly by treatment with 3,5-bis(trifluoromethyl)benzyl bromide without isolating intermediates, combining what were previously separate purification and reaction steps into a continuous manufacturing process.
2Manufacturing precision
If multiple synthetic steps with protecting groups and reactive functional groups are employed, then desired compound structure is achieved, but loss of time and resources increases
Solution Approach 1:
The invention applies preliminary action by performing the sequential reactions in a specific order without isolating intermediates. The compound of formula (2) is treated sequentially with o-tolylmagnesium chloride, N-methylpiperazine, and iodine to form compound (3), which is then immediately treated with 3,5-bis(trifluoromethyl)benzyl bromide. This eliminates time spent on isolation and characterization of intermediate structures while ensuring the correct final compound structure is achieved.
3Manufacturing precision
If reactions are conducted at very high or very low temperatures, then specific reaction outcomes are achieved, but energy consumption and process complexity increase
Solution Approach 1:
The invention applies parameter changes by conducting all reactions at moderate temperatures without requiring extreme heating or cooling. The sequential treatments with various reagents are performed under mild conditions, eliminating the need for very high (130°C) or very low (−78°C) temperatures required by traditional routes, thereby reducing energy consumption while maintaining reaction effectiveness and product structure.
4Manufacturing precision
If chromatographic purification procedures are used for each intermediate, then intermediate purity is ensured, but loss of substance and resource consumption increase
Solution Approach 1:
The invention extracts and removes the chromatographic purification step entirely from the process. Instead of using column chromatography for each intermediate, the method relies on the inherent selectivity of the sequential reactions followed by simple filtration and concentration steps, thereby ensuring adequate purity while eliminating significant material loss and resource consumption associated with chromatographic methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of substituted pyridine compounds and their dihydrochloride salt in kilogram quantities, suitable for medical administration, with improved efficiency and suitability for GMP conditions, reducing processing time and material loss.
Implementation Method 1
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine, under conditions sufficient to obtain a compound of Formula (3)
Implementation Method 2
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine, under conditions sufficient to obtain a compound of Formula (3)
Implementation Method 3
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine, under conditions sufficient to obtain a compound of Formula (3)
Implementation Method 4
treating the compound of Formula (3) from step a) with 3,5-bis(trifluoromethyl)benzyl bromide and a suitable base, under conditions sufficient to obtain a compound of Formula (1)
Implementation Method 5
treating the compound of Formula (1) obtained from step b) with a solution of hydrochloric acid in diethyl ether, under conditions sufficient to obtain a dihydrochloride salt of the compound of Formula (1)
Data Source
AI summary
There is disclosed a method of preparing a compound of Formula (1), or a salt thereof (1) the method comprising: a) treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine, under conditions sufficient to obtain a compound of Formula (3) b) treating the compound of Formula (3) from step a) with 3,5-bis(trifluoromethyl)benzyl bromide and a suitable base, under conditions sufficient to obtain a compound of Formula (1).